CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...

A global study on the neurological effects of the COVID-19 vaccine reveals key trends, with the U.S. leading in publications ...

Moderna has received marketing authorisation from the European Commission for its updated COVID-19 vaccine, Spikevax, which ...

In lab mice trials, researchers found the vaccine delivery method to provide a “far superior” antibody response compared to ...

Texas medical freedom advocates have been pushing against vaccine requirements and recommendations for years. Now, they're in ...

The Covid-19 pandemic turned Moderna and BioNTech into household names almost overnight. Now the two companies find ...

Moderna (MRNA) stock in focus as the company plans to cut 10% of its workforce by 2025 amid cost-saving efforts. Read more ...

Your premium access has ended, but the best of Nation.Africa is still within reach. Renew now to unlock exclusive stories and ...

The global healthcare industry stands at a crossroads. With over 4.2 billion people relying on digital health services, ...

The COVID-19 pandemic upended life for individuals and communities worldwide. Social isolation, health mandates, illness, and economic hardships took a toll on the well-being of families and children, ...

Heart attacks are rising among Indians under 40 due to stress, poor lifestyle, and undiagnosed health issues. Here's what’s ...

Senator Ron Johnson Exposes Government Cover-Up on COVID Vaccine Risks In a scathing Senate testimony, Senator Ron Johnson (R-WI) pulled back the curtain on what many are now call ...